This symposium will be conducted in Japanese Language.
We've closed online registration.
Onsite resistration is still available.
Keiko Tsumori • Associate Director, Medical Writing, Regulatory Affairs Area, Japan Development
MSD K.K., Japan
Hiroko Ebina, MBA, RPh • Principal Writer I
Proscribe KK - Part of the ENVISION PHARMA GROUP, Japan
Yuko Kojima, RPh • Director, Biometrics, Medicine Development Unit - Japan
Eli Lilly Japan K.K., Japan
Miyoshi Masuda • Senior Manager, Medical Writing, Clinical Development Administration
Astellas Pharma Inc., Japan
Satoru Mogami, MSc • Director, Medical Writing & Regulatory Submission
Pfizer Japan Inc., Japan
Junichi Nishino, MSc, RPh • Head, RA Functions Department, Regulatory Office Japan
Novartis Pharma K.K., Japan
Tomoko Okudaira • Reviewer
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Naoko Tejima • Senior Manager, Scientific Writing, Global Regulatory Sciences Japan
Bristol-Myers Squibb K.K., Japan